EDESA BIOTECH INC
(NASDAQ: EDSA)

Edesa Biotech, Inc. is a biopharmaceutical company, which focuses on acquiring, developing, and commercializing clinical stage drugs for inflammatory and immune-related diseases. Its clinical studies include EB05 for Acute Respiratory Distress Syndrome (ARDS), EB07 for systemic sclerosis (SSc), EB01 for chronic Allergic Contact Dermatitis (ACD), EB02 for hemorrhoids, and EB06 for vitiligo. The company was founded by Pardeep Nijhawan on June 12, 2007 and is headquartered in Markham, Canada.

4.192

-0.258 (-5.80%)
Range 4.115 - 4.441   (7.92%)
Open 4.320
Previous Close 4.450
Bid Price 0.959
Bid Volume 22
Ask Price 0.960
Ask Volume 29
Volume 10,218
Value -
Remark
Delayed prices. Updated at 28 Mar 2024 00:00.
Data powered by
View All Events


Top Contributors

USNews avatar
343
Followers 273
Posts 1283231

Loading Chart...

Please login to view stock data and analysis